• Careers
  • News & Events
  • contact
  • Search
  • about axogen
    • about axogen
    • management team
    • board of directors
    • partners
    • international partners
    • ethics and conduct
  • our products
    • Our products
    • Avance® Nerve Graft
    • Axoguard® Nerve Connector
    • Axoguard® Nerve Protector
    • Axoguard® Nerve Cap
    • Avive® Soft Tissue Membrane
    • Axotouch® Two-Point Discriminator
  • For patients
    • patient experiences
    • About the nervous system
    • Causes of Nerve Damage
    • Nerve Damage Treatment Options
    • Peripheral Nerve Injury Map
    • Nerve Term Glossary
  • healthcare professionals
    • healthcare professionals
    • Our clinical research
    • Surgical Technique Videos
    • Understanding the mechanics of nerve repair
    • Registration and Licenses
  • investors
    • News / Events
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • Additional Information

13631 Progress Blvd, Suite 400
Alachua, FL 32615

© 2019 Axogen, Inc.

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Axogen In the News
    • IR Calendar
    • Clinical Conferences
    • Presentations
    • Email Alerts
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Current Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board
  • Additional Info
    • Contacts
    • FAQ
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • Axogen In the News
  • IR Calendar
  • Clinical Conferences
  • Presentations
  • Email Alerts

AxoGen Announces Closing of Public Offering of Common Stock and Underwriters’ Full Exercise of Option to Purchase Additional Shares

Oct 13, 2016

AxoGen Announces Pricing of Public Offering of Common Stock

Oct 7, 2016

AxoGen Announces Proposed Public Offering of Common Stock

Oct 6, 2016

AxoGen, Inc. Appoints Amy Wendell to Board of Directors

Sep 19, 2016

AxoGen to Participate at 71st Annual American Society for Surgery of the Hand Meeting

Sep 15, 2016

AxoGen, Inc. to Participate at the American Association of Oral and Maxillofacial Surgeons 98th Annual Meeting

Sep 12, 2016

AxoGen, Inc. to Present at Wedbush PacGrow Healthcare Conference 2016

Aug 11, 2016

AxoGen, Inc. Reports Financial Results for Second Quarter 2016

Aug 3, 2016

AxoGen, Inc. to Report Second Quarter Financial Results and Host Conference Call on Wednesday, August 3, 2016

Jul 20, 2016

AxoGen, Inc. Added to Russell 2000® Index

Jun 27, 2016
RSS
    • 1...
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • ...25
    Next

    13631 Progress Blvd, Suite 400
    Alachua, FL 32615

    • contact
    • media library
    • Terms of Use
    • Privacy Policy
    • Legal Notices

    © 2021 Axogen Corporation

    Top